I have allergic rhinitis — Annual vaccines for the immune system? Dr. Marcello Bossois

Reading time: 17 min
WhatsApp ↗
Medical Encyclopedia · Allergy and Clinical Immunology

I have allergic rhinitis — Annual vaccines for the immune system? Dr. Marcello Bossois

Clinical Summary and Overview

When symptoms or doubts arise involving Allergic RhinitisDistinguishing between scientifically validated information and palliative care makes all the difference in the evolution of respiratory, skin, and systemic health. This page aims to deepen understanding of... "I have allergic rhinitis — Annual vaccines for the immune system? Dr. Marcello Bossois", providing clear context on how the immune system reacts, which signs require medical attention, and how to structure individualized and effective care.

✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

I have allergic rhinitis — Annual vaccines for the immune system? Dr. Marcello Bossois

Guidelines on Annual Vaccination and Management of Allergic Rhinitis

The search for strategies to strengthen the immune system is common among patients living with allergic rhinitis. However, it is essential to understand that the immunization approach is divided into two distinct fronts: specific vaccination for the treatment of allergies (allergen-specific immunotherapy) and updating the regular vaccination schedule for the prevention of infectious diseases.

Diagnosis and Immunotherapy for Allergic Rhinitis

The first step in the proper treatment of allergic rhinitis is diagnostic confirmation by a specialist physician. Not all rhinitis is of allergic origin; other conditions require different therapeutic approaches. When an allergic profile is confirmed through complementary tests, such as an allergy test (prick test), the result must be associated with the clinical symptoms presented by the patient.

Based on this confirmation, specific desensitizing immunotherapy can be indicated, often targeting mites that are predominant in the population, such as... Blomia tropicalis and the Dermatophagoides pteronyssinus...in addition to specific molecular components associated with the clinical picture. Although the public health system has referral centers, the high demand often directs patients to follow-up care in specialized clinics in the private sector.

Vaccination Schedule Update and Respiratory Protection

In addition to managing rhinitis, it is extremely important to keep vaccination records up to date with the immunizations provided by the Ministry of Health and recommended by medical societies, covering children, adolescents, adults, and the elderly. Prevention against common respiratory infections, such as influenza (with trivalent options in the public network and quadrivalent options in the private network) and pneumococcal infections, plays a significant protective role in overall health.

Maintaining proper control of allergic rhinitis brings direct benefits to the defense of the airways. Inflamed nasal mucosa and altered ciliary beating—a natural defense and filtration mechanism of the respiratory tract—can facilitate the adhesion and penetration of infectious agents. Therefore, controlling allergic inflammation and maintaining up-to-date immunizations work together to preserve the integrity of the immune and respiratory barrier.

This content is strictly educational and informative in nature and should in no way replace consultation, diagnosis, and individualized evaluation with a specialist physician.

Developments in Evidence-Based Medicine: The Unified Airway Concept (ARIA/EPOS)

The international ARIA consensuses (Allergic Rhinitis and its Impact on Asthma) and EPOS (European Position Paper on Rhinosinusitis and Nasal Polyps) consolidate the pathophysiological concept of single (unified) air routeThe nasal mucosa, paranasal sinuses, and tracheobronchial tree share the same ciliated pseudostratified respiratory epithelium and the same immunological mechanisms mediated by IgE, mast cells, and eosinophils. Persistent edema of the sinus drainage ostia in uncontrolled allergic rhinitis predisposes to mucociliary stasis, post-nasal drip, recurrent rhinosinusitis, and bronchial hyperreactivity. Evidence-based management integrates nasal hygiene with isotonic/hypertonic saline solution, topical intranasal corticosteroids, environmental control, and... allergen-specific immunotherapy to induce lasting immune tolerance.

💎 Diamond Plan — Safe immunization, even for those with a history of allergies. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Unified Airway: Management of Rhinitis, Rhinosinusitis, and Nasal Hypersensitivity

Inflammation of the Respiratory Mucosa, House Mites, and Local Complications

The nose performs vital functions of filtering, warming, and humidifying inhaled air before it reaches the lungs. In allergic rhinitis and chronic rhinosinusitis, contact between aeroallergens—especially house dust mites (Dermatophagoides pteronyssinus and Blomia tropicalis), anemophilous fungi, and epithelia—and IgE antibodies fixed to mast cells in the nasal mucosa triggers the immediate release of histamine, leukotrienes, and prostaglandins. This process generates nasal obstruction, itching, sneezing fits, post-nasal drip (a frequent cause of chronic nighttime cough), and vascular fragility that can favor minor bleeding (epistaxis) due to trauma from blowing the nose or from poorly directed sprays.

Nasal Irrigation, Safe Topical Sprays, and Desensitizing Immunotherapy

Environmental hygiene measures in the bedroom — waterproofing of mattresses and pillows, solar ventilation, and removal of dust reservoirs — go hand in hand with the allergy test and the rhinitis treatment individualized. When indicated by the specialist, the allergy vaccine It reduces nasal congestion in a lasting way and prevents the progression to recurrent sinusitis and bronchial hyperreactivity.

Epithelial Dysfunction, Skin Microbiome, and Delayed Sensitization

In eczematous dermatitis and cases of chronic pruritus, differentiating constitutional atopy from allergic contact dermatitis (a type IV delayed hypersensitivity reaction mediated by T lymphocytes sensitized to metals, cosmetic preservatives, fragrances, resins, or rubber) is essential. Repeated exposure to the sensitizing agent maintains active skin inflammation even with the use of anti-inflammatory ointments, requiring precise identification of the triggering factor.

Vaccine Mechanisms, Excipients, and Assessment of Immune Competence

Preventive immunization represents one of the greatest achievements of medicine in reducing hospitalizations and serious infectious complications, especially in patients with chronic respiratory diseases (such as asthma and COPD), heart disease, high blood pressure, and diabetes. Patients allergic to aeroallergens, foods, or common medications do not have a general contraindication to vaccines; allergological attention focuses on the specific evaluation of rare cases of previous anaphylaxis to isolated components of the formula (such as polyethylene glycol, polysorbate, or specific protein traces), situations that now have safe assisted application protocols.

Clinical Safety Criteria and Warning Signs in Allergology

Early recognition of warning signs requiring priority medical reassessment is part of the health education of every patient and their family. Symptoms such as progressive dyspnea (difficulty breathing or speaking in complete sentences), refractory wheezing, sudden edema of the lips, tongue, or glottis, dizziness due to a drop in blood pressure, persistent fever associated with skin lesions or mucous membrane involvement require immediate emergency care, followed by a structured allergy investigation to prevent future recurrences.

Impact on Quality of Life, Sleep, and Systemic Well-being

Beyond the direct physical manifestations, uncontrolled conditions linked to allergic rhinitis profoundly interfere with restorative sleep patterns, concentration at school and work, and emotional balance. Chronic stress, through neuroendocrine mediators and epithelial alarmins, reinforces the immune inflammatory response. Therefore, instituting a comprehensive approach to clinical and environmental rehabilitation restores daily autonomy and overall well-being of the individual.

Importance of Differential Diagnosis and Detailed Medical History

In the specialty of Allergy and Immunology, two patients with seemingly similar symptoms involving Allergic Rhinitis may present completely distinct pathophysiological mechanisms. For this reason, a thorough clinical history—investigating the chronology of flare-ups, home and work environment, family history of atopy, use of concomitant medications, and dietary habits—serves as an indispensable guide for correctly interpreting laboratory tests (such as total and specific IgE levels) and functional tests. A single laboratory result can never replace in-person clinical judgment or specialized telemedicine, preventing misdiagnosis and unnecessary treatments.

Environmental Prevention, Therapeutic Adherence, and Continuous Monitoring

Long-term success in managing allergic and immunological conditions depends directly on the alliance between targeted medical treatment and daily educational measures. Maintaining well-ventilated environments free from accumulated household dust, preserving the physiological hydration of mucous membranes and the skin barrier, strictly adhering to the schedules and technique for using prescribed preventive medications, and conducting periodic check-ups allow for the stabilization of subclinical inflammation before it progresses to acute exacerbations.

Frequently Asked Questions in Clinical Practice

Immunological Reactions to Insect Bites and Prevention of Crises: Reactions triggered by arthropods are clinically divided between hypersensitivity to the saliva of hematophagous insects (such as mosquitoes, black flies, and fleas, which cause papular urticaria in childhood) and systemic allergy to the venom of hymenoptera (bees, wasps, and fire ants). While salivary antigens usually generate persistent pruritic papules and a risk of secondary bacterial infection from scratching, venom injected by a stinger can trigger massive mast cell degranulation mediated by IgE antibodies, requiring evaluation of baseline serum tryptase and an emergency action plan.

Mechanisms of Food Allergy, Accurate Diagnosis and Nutritional Management: The immune system associated with the gastrointestinal mucosa normally functions by maintaining oral tolerance to thousands of dietary proteins. When this immune barrier is broken—influenced by genetic predisposition, dysbiosis of the intestinal microbiota, or immaturity of secretory IgA in childhood—intact protein fractions sensitize mast cells and basophils. Therefore, a single positive blood test reflects only biological sensitization and should always be correlated with the clinical history and, when necessary, with a supervised oral food challenge in a medical setting.

Immunology of the Digestive Mucosa: Gut-Airway Axis and Differential Diagnosis: Immune-mediated disorders of the gastrointestinal tract—including eosinophilic esophagitis, celiac disease, and non-celiac gluten sensitivity—share alterations in the integrity of the tight junctions of the digestive epithelium. In eosinophilic esophagitis, frequently associated with rhinitis, asthma, and atopic dermatitis, eosinophil infiltration of the esophageal wall causes dysphagia, food impaction, and symptoms that mimic gastroesophageal reflux refractory to proton pump inhibitors.

Skin Barrier Health, Immune Inflammation, and Pruritus Control: In eczematous dermatitis and cases of chronic pruritus, differentiating constitutional atopy from allergic contact dermatitis (a type IV delayed hypersensitivity reaction mediated by T lymphocytes sensitized to metals, cosmetic preservatives, fragrances, resins, or rubber) is essential. Repeated exposure to the sensitizing agent maintains active skin inflammation even with the use of anti-inflammatory ointments, requiring precise identification of the triggering factor.

Immunology of Cutaneous Autoimmune Diseases and Integrated Care: Unlike purely IgE-mediated dermatoses, psoriasis and related autoimmune conditions involve the activation of plasmacytoid dendritic cells, interferon-gamma production, and sustained stimulation of the interleukin-23/interleukin-17 (IL-23/IL-17) and TNF-alpha axis. This signaling accelerates the epidermal keratinocyte renewal cycle several times over, resulting in well-defined erythematous-desquamative plaques and, in some patients, associated joint inflammation. Infections, mechanical or chemical trauma to the skin (Koebner phenomenon), dry winter weather, and emotional stress act as important amplifiers of the inflammatory response.

Pathophysiology of Urticaria and Angioedema: Safe Diagnosis and Management: When isolated recurrent angioedema occurs without surrounding pruritic plaques, immunological reasoning must distinguish histaminergic conditions from those mediated by bradykinin—including hereditary or acquired angioedema due to functional or quantitative deficiency of C1-esterase inhibitor (C1-INH) and reactions induced by angiotensin-converting enzyme (ACE) inhibitor antihypertensive drugs. This differentiation is vital because bradykinin-related angioedema does not respond to conventional antihistamines or corticosteroids.

Control of Bronchial Inflammation, Lung Function, and Prevention of Remodeling: Bronchial asthma and allergic bronchitis are chronic inflammatory diseases of the lower airways, characterized by bronchial hyperreactivity, mucosal edema, mucus hypersecretion, and variable obstruction to expiratory airflow. When eosinophilic or allergic inflammation (type 2) remains uncontrolled over the years—or when the patient uses only short-term bronchodilators without treating the underlying inflammation—thickening of the basement membrane and hypertrophy of the bronchial smooth muscle occur, a process known as bronchial remodeling.

Pharmacological Safety, Adverse Drug Reactions, and Rational Use of Corticosteroids: Drug hypersensitivity reactions encompass distinct immunological and pharmacological mechanisms: from immediate reactions (up to one to six hours after dosing, manifested by urticaria, labial or palpebral angioedema, bronchospasm, and anaphylaxis, common with COX-1 inhibitor analgesics and beta-lactams) to delayed drug eruptions mediated by T cells, such as maculopapular rashes and DRESS syndrome — a systemic condition that arises weeks after the start of anticonvulsants, sulfones, or allopurinol, presenting with fever, lymphadenomegaly, eosinophilia, and the need for immediate discontinuation under hospital supervision.

Safe Immunization, Immune Response, and Protection of the Allergic Patient: In assessing the competence of the immune system—whether in recurrent infections, laboratory alterations in immunoglobulins (IgG, IgA, IgM, IgE), or in people living with HIV under monitoring of CD4 T lymphocyte counts—a careful distinction is made between the use of inactivated/subunit vaccines (widely safe even in immunocompromised individuals) and live attenuated vaccines, whose indication depends on the degree of preservation of cellular immunity. Furthermore, patients undergoing allergy immunotherapy can maintain their vaccination schedule, respecting only small operational intervals as directed by the medical team.

Precision Medicine: How Monoclonal Antibodies and Immunobiologics Work: Monoclonal antibodies (immunobiologics) have revolutionized the management of severe allergic and immune-mediated diseases that do not achieve full control with conventional therapies. Unlike systemic corticosteroids and classic immunosuppressants—which broadly depress immunity and generate metabolic toxicity—immunobiologics act as highly precise molecular keys, neutralizing specific targets of the inflammatory cascade: such as circulating free IgE (omalizumab), the IL-4 and IL-13 receptor (dupilumab), the eosinophilic pathway of IL-5 (mepolizumab and benralizumab), or the epithelial alarmin TSLP (tezepelumab).

Diamond Plan: Specialized Allergy Treatment Wherever You Are

SIGNATURE
DIAMOND

Allergy-Free Brazil

THE FUTURE OF TREATMENT

💎

  • Allergy and immunostimulant vaccines included.
  • Easy access (upon request)
  • Nationwide coverage — all of Brazil

brasilsemalergia.online

Treating the cause of an allergy requires consistency — and consistency requires access. Diamond Plan It was designed for patients throughout Brazil who face the high cost of allergy vaccines and the difficulties of travel, offering specialized follow-up via telemedicine and easy access to immunotherapy treatment. Safe immunization, even for those with a history of allergies.

Why do patients across Brazil choose the Diamond Plan?

  • Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
  • easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
  • A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
  • Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
  • National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.

More than 30 years caring for people with allergies.

Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.

START TODAY

Your expert consultation is just a click away.

I want to join the Diamond Plan.Schedule a teleconsultation

Official telemedicine environment: brasilsemalergia.online

Do you prefer to be served in person?

Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:

Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.

The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Conclusion and Summary of Guidelines

In summary, the appropriate approach to Allergic Rhinitis It requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoiding self-medication and investigating the root cause of symptoms—relying on specialized resources and reliable guidance such as specialized allergy and immunology care when clinically relevant—is the safest way to control flare-ups, prevent complications, and ensure sustainable quality of life.

Scientific references and authoritative sources

The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information: